News Sun Pharmaceutical Industries Ltd.

Stocks

SUNPHARMA

INE044A01036

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:09 08/06/2026 pm IST			5-day change	1st Jan Change
1,788.80 ^INR	+0.37%		-0.58%	+4.02%

26/05	Sun Pharmaceutical Industries Limited Presents Updated Results from Locally Advanced Cutaneous Squamous Cell Carcinoma Expansion Cohort from Pivotal CK-301-101 Trial of UNLOXCYT (Cosibelimab-Ipdl) at ASCO 2026 Annual Meeting	CI
26/05	Sun Pharma to present long-term follow-up data on Unloxcyt	RE

All News

Mentions Relevance

26/05	Sun Pharmaceutical Industries Limited Presents Updated Results from Locally Advanced Cutaneous Squamous Cell Carcinoma Expansion Cohort from Pivotal CK-301-101 Trial of UNLOXCYT (Cosibelimab-Ipdl) at ASCO 2026 Annual Meeting	CI
26/05	Sun Pharma to present long-term follow-up data on Unloxcyt	RE
22/05	Sun Pharmaceutical Industries Limited, Q4 2026 Earnings Call, May 22, 2026
22/05	Sun Pharmaceutical Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
22/05	Sun Pharmaceutical Industries Consolidated Profit Grows in Fiscal Q4; Shares Slip 3	MT
22/05	Sun Pharmaceutical Industries Limited Recommends Final Dividend for the Fiscal Year Ended March 31, 2026	CI
22/05	India's Sun Pharma posts profit beat on specialty drug demand, shares slide on cost pressures	RE
22/05	Sun Pharma Q4 consol net PAT 27.14 billion rupees	RE
12/05	Sun Pharmaceutical Industries Limited Announces Retirement of Rama Bijapurkar as Independent Director, Effective 12 May 2026	CI
08/05	Sun Pharma To Acquire Organon	AQ
28/04	India’s Sun Pharma agrees all cash takeover of Organon	AQ
27/04	PRESS DIGEST-Wall Street Journal - April 27	RE
27/04	Sun Pharmaceutical to Acquire US-Based Organon in $11.8 Billion Deal	MT
27/04	Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal	RE
24/04	Sun Pharma incorporates Sun Pharma America, Inc. in United States	RE
24/04	Sun Pharmaceutical Industries Forms New Wholly-Owned Subsidiary in US; Shares Down 4%	MT
14/04	Sun Pharmaceutical Industries Enjoys Global Dose of Success
27/03	Sun Pharmaceutical Industries Limited Highlights Advances In Alopecia Areata, Psoriasis, And Acne Research At 2026 AAD Annual Meeting	CI
21/03	Sun Pharma launches its semaglutide injection under brand names, Noveltreat and Sematrinity in India	RE
21/03	Sun Pharmaceutical Industries Limited Launches Semaglutide Injection Under the Brand Names Noveltreat and Sematrinity in India	CI
16/03	Sun Pharma announces US FDA acceptance of supplemental biologics license (SBLA) application for Ilumya® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis	RE
16/03	Sun Pharma - US FDA accepts sBLA for Ilumya for active psoriatic arthritis	RE
16/03	Sun Pharmaceutical Industries Limited Announces Us Fda Acceptance of Supplemental Biologics License Application for Ilumya for Treatment of Adults with Active Psoriatic Arthritis	CI
02/03	Sun Pharma Showcases Data Across its Dermatology & Immunology Portfolio at 2026 Winter Clinical Miami	AQ
27/02	Sun Pharmaceutical Industries Limited Showcases Data Across Its Dermatology & Immunology Portfolio At 2026 Winter Clinical Miami	CI